CLINICAL_TRIALS
trial_result
· 2011-12-29
Clinical Trial Update: Beta-Cell Function and Sitagliptin Trial (BEST) [Phase 2]
Summary
A Phase 2 trial (BEST) evaluating sitagliptin on beta-cell function in Type 2 Diabetes Mellitus has completed, with results posted on 2011-12-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2011-12-29